Search For "trial"
ICMR-Bharat Biotech COVID-19 vaccine trial results to be released by Aug 1
Updated : 5 years, 8 months ago IST
New Delhi [India], July 3 (ANI) The Indian Council of Medical Research (ICMR) DG Balram Bhargava has written a letter to Bharat Biotech and principal investigators of medical colleges to complete the trial procedure of indigenous COVID-19 vaccine in a fast track method, so that results of
Read More
DCGI permits human clinical trials for COVID-19 vaccine of Zydus Cadila
Updated : 5 years, 8 months ago IST
New Delhi [India], July 3 (ANI): The Drug Controller General of India (DCGI) on Thursday granted permission to pharma giant Zydus Cadila to conduct phase I and phase II human clinical trials for COVID -19 vaccine, a top government official told ANI.
Read More
Persons with physical infirmities seriously affecting cognitive functions
Updated : 5 years, 8 months ago IST
Kochi (Kerala) [India], July 1 (ANI): The Kerala High Court on Wednesday said that persons having physical infirmities like deafness or dumbness which seriously affect their cognitive functions can file a suit through "next friend".
Read More
US approved 4 COVID-19 vaccine candidates for clinical trials - FDA Head
Updated : 5 years, 8 months ago IST
Washington [US], July 1 (Sputnik/ANI): The United States has approved four coronavirus vaccine candidates for clinical trials, Food and Drug Administration (FDA) head Stephen Hahn told reporters.
Read More
Trial run of train engine conducted on Pamban railway bridge in Rameswaram
Updated : 5 years, 8 months ago IST
Rameswaram (Tamil Nadu) [India], June 30 (ANI): The trial run of train engine was performed on the Pamban railway bridge in Rameswaram on Tuesday.
Read More
UK's RECOVERY trial found anti-viral HIV drug "ineffective"on COVID-19 pat
Updated : 5 years, 8 months ago IST
New Delhi [India], June 30 (ANI): Researchers from UK's RECOVERY trial (Randomised Evaluation of COVID-19 Therapy) have claimed to have found no benefit from anti-viral HIV drug-- 'lopinavir-ritonavir' administered in patients hospitalised COVID-19 patients.
Read More
DCGI gives nod to Bharat Biotech to conduct phase I & II Human clinica
Updated : 5 years, 8 months ago IST
New Delhi [India], June 30 (ANI): The Drug Controller General of India (DCGI) has granted permission to Bharat Biotech International Limited (BBIL) to conduct Phase I and II Human clinical trials to develop an indigenous vaccine for COVID-19 -- in the name COVAXIN.
Read More
GNP can be used as 'composite therapeutic agent' in clinical trials: Dr Ha
Updated : 5 years, 8 months ago IST
New Delhi [India], June 30 (ANI): Union Health Minister Dr Harsh Vardhan on Tuesday said that the Gold Nanoparticles synthesized by the National Centre for Polar and Ocean Research and Goa University can be used as a "composite therapeutic agent" in clinical trials for anti-cancer, anti-vira
Read More
Bharat Biotech announces India's first COVID-19 vaccine candidate 'COVAXIN
Updated : 5 years, 8 months ago IST
Hyderabad (Telangana) [India], June 30 (ANI): Hyderabad-based Bharat Biotech announced that it has successfully developed Covaxin, India's first vaccine candidate for Covid-19, in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV). Read More
Maharashtra CM inaugurates 'Project PLATINA', world's largest convalescent
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], June 29 (ANI): Maharashtra Chief Minister Uddhav Thackeray on Monday inaugurated 'Project PLATINA', world's largest convalescent plasma therapy trial cum treatment of severe COVID-19 patients.
Read More
ICMR identifies PGIMER for validation of Rapid Antigen Detection Assays fo
Updated : 5 years, 8 months ago IST
Chandigarh [India], June 28 (ANI): The Indian Council of Medical and Research (ICMR) has initiated a programme of clinical trials for rapid antigen detection assays for COVID-19 patients and PGIMER, Chandigarh has been selected as one of seven premier tertiary care hospitals across the count
Read More
Health ministry recommends use of Dexamethasone drug for managing moderate
Updated : 5 years, 8 months ago IST
New Delhi [India], June 27 (ANI): The Union Health Ministry has included the use of Dexamethasone as an alternative to Methylprednisolone for managing moderate to severe COVID-19 cases.
Read More